Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

NGFR P210 Citations (2)

Originally described in: The coiled-coil domain and Tyr177 of bcr are required to induce a murine chronic myelogenous leukemia-like disease by bcr/abl.
He Y, Wertheim JA, Xu L, Miller JP, Karnell FG, Choi JK, Ren R, Pear WS. Blood. 2002 Apr 15;99(8):2957-68.
PubMed Journal

Articles Citing NGFR P210

Articles
Extracellular matrix stiffness causes systematic variations in proliferation and chemosensitivity in myeloid leukemias. Shin JW, Mooney DJ. Proc Natl Acad Sci U S A. 2016 Oct 25;113(43):12126-12131. Epub 2016 Oct 10. PubMed
Novel combined Ato-C treatment synergistically suppresses proliferation of Bcr-Abl-positive leukemic cells in vitro and in vivo. Wahiduzzaman M, Ota A, Karnan S, Hanamura I, Mizuno S, Kanasugi J, Rahman ML, Hyodo T, Konishi H, Tsuzuki S, Takami A, Hosokawa Y. Cancer Lett. 2018 Oct 1;433:117-130. doi: 10.1016/j.canlet.2018.06.027. Epub 2018 Jun 23. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.